profit from every $100 of sales.
$0$100
HeartBeam
$0.01+112.50% today
-86.1% in 1 year
1-year low $0.001-year high $0.10
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
It holds more cash than debt.
No debt5 years
HeartBeam vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| HeartBeam | No profit yet | ||
 GE HealthCare Technologies | 18.0× · Fair price | ||
 BrightSpring Health Services | 74.3× · Very expensive | ||
 Tempus AI | No profit yet | ||
 HealthEquity | 39.8× · Expensive |
AI analysis
An AI analyst reads HeartBeam's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- 61.7×
- 0.0×
- –
- –
- -440.7%
- -51.7%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -3,205.2%
- -530.8%
- -1,034.0%
- -514.9%
- -3,205.2%
- –
Growth
- –
- –
- +0.6%
- –
- +44.1%
Financial health
- -0.1×
- 0.00
- 0.0%
- –
- 0.74
- 0.70
- 0.00
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 19%of 898
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.12 | -0.14 | +11.1% |
| Mar 12, 2026 | -0.14 | -0.14 | −1.8% |
| Nov 13, 2025 | -0.15 | -0.13 | −18.1% |
| Aug 13, 2025 | -0.15 | -0.16 | +8.1% |
| May 13, 2025 | -0.18 | -0.15 | −20.3% |
| Jun 30, 2023 | -0.00 | – | – |
| Mar 31, 2023 | -0.00 | – | – |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
16No pass
Benjamin Graham
22No pass
Philip Fisher
31No pass
Peter Lynch
60Pass
Joel Greenblatt
0No pass
Charlie Munger
37No pass
Terry Smith
32No pass
Questions about HeartBeam
Is HeartBeam a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the HeartBeam AI analysis
What does HeartBeam do?
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. It is in Medical - Healthcare Information Services.
Does HeartBeam pay a dividend?
No. HeartBeam does not pay a dividend at the moment.
How has HeartBeam stock done over the past year?
Down 86.1% over the past twelve months, to $0.01. It traded between $0.00 and $0.10 and is 91.5% below its high.
Who are HeartBeam's competitors?
The largest listed companies in the same industry are GE HealthCare Technologies, BrightSpring Health Services, Tempus AI and HealthEquity. The peers table on this page compares their profit, growth and price with HeartBeam's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.